
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting Toll-Like Receptors for Cancer Therapy
Marc J. Braunstein, John Kucharczyk, Sylvia Adams
Targeted Oncology (2018) Vol. 13, Iss. 5, pp. 583-598
Closed Access | Times Cited: 98
Marc J. Braunstein, John Kucharczyk, Sylvia Adams
Targeted Oncology (2018) Vol. 13, Iss. 5, pp. 583-598
Closed Access | Times Cited: 98
Showing 1-25 of 98 citing articles:
The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
Zuzanna Urban‐Wójciuk, Mohd M. Khan, Benjamin L. Oyler, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 258
Zuzanna Urban‐Wójciuk, Mohd M. Khan, Benjamin L. Oyler, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 258
Toll-like receptor signalling in B cells during systemic lupus erythematosus
Simon Fillatreau, Benoît Manfroi, Thomas Dörner
Nature Reviews Rheumatology (2020) Vol. 17, Iss. 2, pp. 98-108
Open Access | Times Cited: 225
Simon Fillatreau, Benoît Manfroi, Thomas Dörner
Nature Reviews Rheumatology (2020) Vol. 17, Iss. 2, pp. 98-108
Open Access | Times Cited: 225
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
Baharak Bahmani, Hua Gong, Brian T. Luk, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 218
Baharak Bahmani, Hua Gong, Brian T. Luk, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 218
Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility
Aga Syed Sameer, Saniya Nissar
BioMed Research International (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 212
Aga Syed Sameer, Saniya Nissar
BioMed Research International (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 212
Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
Nataschja I. Ho, Lisa G. M. Huis in ’t Veld, Tonke K. Raaijmakers, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 187
Nataschja I. Ho, Lisa G. M. Huis in ’t Veld, Tonke K. Raaijmakers, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 187
Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 51
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 51
Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors
Kuo‐Ching Mei, Yu‐Pei Liao, Jinhong Jiang, et al.
ACS Nano (2020) Vol. 14, Iss. 10, pp. 13343-13366
Open Access | Times Cited: 132
Kuo‐Ching Mei, Yu‐Pei Liao, Jinhong Jiang, et al.
ACS Nano (2020) Vol. 14, Iss. 10, pp. 13343-13366
Open Access | Times Cited: 132
Small extracellular vesicles in cancer
Komal Abhange, Amy Makler, Yi Wen, et al.
Bioactive Materials (2021) Vol. 6, Iss. 11, pp. 3705-3743
Open Access | Times Cited: 102
Komal Abhange, Amy Makler, Yi Wen, et al.
Bioactive Materials (2021) Vol. 6, Iss. 11, pp. 3705-3743
Open Access | Times Cited: 102
RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF‐κB pathway
Yi Jiang, Yicong Wan, Mi Gong, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 11, pp. 6137-6148
Open Access | Times Cited: 86
Yi Jiang, Yicong Wan, Mi Gong, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 11, pp. 6137-6148
Open Access | Times Cited: 86
Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
Mariya Farooq, Maria Batool, Moon Suk Kim, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 71
Mariya Farooq, Maria Batool, Moon Suk Kim, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 71
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
Haowei Sun, Yingmei Li, Peng Zhang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 68
Haowei Sun, Yingmei Li, Peng Zhang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 68
Recent advances in immunotherapy, immunoadjuvant, and nanomaterial-based combination immunotherapy
Benqing Zhou, Jinxing Liu, Meiai Lin, et al.
Coordination Chemistry Reviews (2021) Vol. 442, pp. 214009-214009
Closed Access | Times Cited: 59
Benqing Zhou, Jinxing Liu, Meiai Lin, et al.
Coordination Chemistry Reviews (2021) Vol. 442, pp. 214009-214009
Closed Access | Times Cited: 59
Polymeric nanoparticle gel for intracellular mRNA delivery and immunological reprogramming of tumors
Sarah Y. Neshat, Chun Hei Ryan Chan, Jawaun J. Harris, et al.
Biomaterials (2023) Vol. 300, pp. 122185-122185
Open Access | Times Cited: 26
Sarah Y. Neshat, Chun Hei Ryan Chan, Jawaun J. Harris, et al.
Biomaterials (2023) Vol. 300, pp. 122185-122185
Open Access | Times Cited: 26
Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota
Antonino Di Lorenzo, Elisabetta Bolli, Lidia Tarone, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9418-9418
Open Access | Times Cited: 57
Antonino Di Lorenzo, Elisabetta Bolli, Lidia Tarone, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9418-9418
Open Access | Times Cited: 57
Emerging Autophagy Functions Shape the Tumor Microenvironment and Play a Role in Cancer Progression - Implications for Cancer Therapy
Silvina Odete Bustos, Fernanda Antunes, María Cristina Rangel, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 56
Silvina Odete Bustos, Fernanda Antunes, María Cristina Rangel, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 56
The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies
Hasan Baysal, Ines De Pauw, Hannah Zaryouh, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47
Hasan Baysal, Ines De Pauw, Hannah Zaryouh, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47
MMP2 and TLRs modulate immune responses in the tumor microenvironment
Luciana Rebiero Muniz-Bongers, Christopher B. McClain, Mansi Saxena, et al.
JCI Insight (2021) Vol. 6, Iss. 12
Open Access | Times Cited: 43
Luciana Rebiero Muniz-Bongers, Christopher B. McClain, Mansi Saxena, et al.
JCI Insight (2021) Vol. 6, Iss. 12
Open Access | Times Cited: 43
The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
Lingling Huang, Xiaoyan Ge, Yang Liu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1228-1228
Open Access | Times Cited: 34
Lingling Huang, Xiaoyan Ge, Yang Liu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1228-1228
Open Access | Times Cited: 34
Toll-like receptors in breast cancer immunity and immunotherapy
Joseph J. P. Zhou, Lin Zhang, Siyao Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Joseph J. P. Zhou, Lin Zhang, Siyao Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Synbiotic fermented soymilk with Weissella cibaria FB069 and xylooligosaccharides prevents proliferation in human colon cancer cells
Bao Le, Anh Pham Thi Ngoc, Seung Hwan Yang
Journal of Applied Microbiology (2019) Vol. 128, Iss. 5, pp. 1486-1496
Closed Access | Times Cited: 48
Bao Le, Anh Pham Thi Ngoc, Seung Hwan Yang
Journal of Applied Microbiology (2019) Vol. 128, Iss. 5, pp. 1486-1496
Closed Access | Times Cited: 48
In situimmunization of a TLR9 agonist virus-like particle enhances anti-PD1 therapy
Yinwen Cheng, Caitlin D. Lemke, Wattawan Wongpattaraworakul, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000940-e000940
Open Access | Times Cited: 45
Yinwen Cheng, Caitlin D. Lemke, Wattawan Wongpattaraworakul, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000940-e000940
Open Access | Times Cited: 45
Promising targets based on pattern recognition receptors for cancer immunotherapy
Ling Bai, Wenqian Li, Weijia Zheng, et al.
Pharmacological Research (2020) Vol. 159, pp. 105017-105017
Open Access | Times Cited: 44
Ling Bai, Wenqian Li, Weijia Zheng, et al.
Pharmacological Research (2020) Vol. 159, pp. 105017-105017
Open Access | Times Cited: 44
Immune Landscape in Tumor Microenvironment: Implications for Biomarker Development and Immunotherapy
Karim Pérez-Romero, Ramón María Alvargonzález Rodríguez, Amedeo Amedei, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5521-5521
Open Access | Times Cited: 39
Karim Pérez-Romero, Ramón María Alvargonzález Rodríguez, Amedeo Amedei, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5521-5521
Open Access | Times Cited: 39
TLRs as a Promise Target Along With Immune Checkpoint Against Gastric Cancer
Lin Cui, Xiuqing Wang, Dekai Zhang
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 37
Lin Cui, Xiuqing Wang, Dekai Zhang
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 37
The abscopal effect: a sense of DNA damage is in the air
Timothy P. Lippert, Roger A. Greenberg
Journal of Clinical Investigation (2021) Vol. 131, Iss. 9
Open Access | Times Cited: 33
Timothy P. Lippert, Roger A. Greenberg
Journal of Clinical Investigation (2021) Vol. 131, Iss. 9
Open Access | Times Cited: 33